DK222790D0 - Biologisk aktivt materiale karakteriseret ved katabolisk aktivitet, alment associeret med cachexia-inducerende tumorer, praeparater, produktion og anvendelse deraf - Google Patents

Biologisk aktivt materiale karakteriseret ved katabolisk aktivitet, alment associeret med cachexia-inducerende tumorer, praeparater, produktion og anvendelse deraf

Info

Publication number
DK222790D0
DK222790D0 DK222790A DK222790A DK222790D0 DK 222790 D0 DK222790 D0 DK 222790D0 DK 222790 A DK222790 A DK 222790A DK 222790 A DK222790 A DK 222790A DK 222790 D0 DK222790 D0 DK 222790D0
Authority
DK
Denmark
Prior art keywords
catbolic
cachexia
preparations
activity
production
Prior art date
Application number
DK222790A
Other languages
English (en)
Other versions
DK222790A (da
Inventor
Michael John Tisdale
Susan Anne Beck
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of DK222790D0 publication Critical patent/DK222790D0/da
Publication of DK222790A publication Critical patent/DK222790A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
DK222790A 1988-03-18 1990-09-17 Biologisk aktivt materiale karakteriseret ved katabolisk aktivitet, alment associeret med cachexia-inducerende tumorer, praeparater, produktion og anvendelse deraf DK222790A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806471A GB8806471D0 (en) 1988-03-18 1988-03-18 Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours
PCT/GB1989/000296 WO1989008709A1 (en) 1988-03-18 1989-03-20 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof

Publications (2)

Publication Number Publication Date
DK222790D0 true DK222790D0 (da) 1990-09-17
DK222790A DK222790A (da) 1990-09-17

Family

ID=10633675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK222790A DK222790A (da) 1988-03-18 1990-09-17 Biologisk aktivt materiale karakteriseret ved katabolisk aktivitet, alment associeret med cachexia-inducerende tumorer, praeparater, produktion og anvendelse deraf

Country Status (9)

Country Link
US (2) US5219579A (da)
EP (1) EP0335550A1 (da)
JP (1) JPH05504543A (da)
AU (1) AU637046B2 (da)
DK (1) DK222790A (da)
GB (2) GB8806471D0 (da)
IE (1) IE890873L (da)
WO (1) WO1989008709A1 (da)
ZA (1) ZA892104B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
EP0662324A1 (en) * 1987-09-15 1995-07-12 The Rowett Research Institute Use of beta-adrenergic agonists for treating loss of function of striated muscles
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
GB8906369D0 (en) * 1989-03-20 1989-05-04 Tisdale Michael J Eicosapentaenoic acid
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
AU4199597A (en) * 1996-09-09 1998-04-02 Novo Nordisk A/S A cdna and peptide with relation to cancer and weight loss
JPH11269079A (ja) * 1998-03-17 1999-10-05 Shiseido Co Ltd 脂質分解促進用皮膚外用剤
US6354297B1 (en) * 1998-04-16 2002-03-12 The Uniformed Services University Of The Health Sciences Method and device for destroying fat cells by induction of programmed cell death
GB9811465D0 (en) * 1998-05-29 1998-07-29 Tisdale Michael J Glycoproteins having lipid mobilising properties and therapeutic applications thereof
US20020022036A1 (en) 2000-08-21 2002-02-21 Riordan Neil H. Method for inducing an anti-tumor and anti-cachexia immune response in mammals
US6852693B2 (en) 2002-02-07 2005-02-08 Blm Group Compositions and methods for promoting lipid mobilization in humans
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
RU2005128501A (ru) * 2003-02-13 2006-04-27 Веллстат Терапьютикс Корпорейшн (Us) Соединение для лечения метаболических расстройств
CA2521621C (en) * 2003-04-15 2011-11-01 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7184267B2 (en) * 2003-12-12 2007-02-27 Hewlett-Packard Development Company, Lp. Longitudinally cooled electronic assembly
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
US7361081B2 (en) * 2004-07-23 2008-04-22 Hewlett-Packard Development Company, L.P. Small form factor air jet cooling system
US10191033B2 (en) 2013-12-05 2019-01-29 The Broad Institute, Inc. Biomarkers for detecting pre-cachexia or cachexia and methods of treatment thereof
US11111296B2 (en) 2015-12-14 2021-09-07 The Broad Institute, Inc. Compositions and methods for treating cardiac dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650150T2 (de) * 1985-08-16 1995-04-27 The Rockefeller University, New York, N.Y. Modulator der anabolischen Aktivität und seine Verwendungen.

Also Published As

Publication number Publication date
JPH05504543A (ja) 1993-07-15
IE890873L (en) 1989-09-18
AU637046B2 (en) 1993-05-20
EP0335550A1 (en) 1989-10-04
ZA892104B (en) 1990-05-30
AU3426389A (en) 1989-10-05
US5385740A (en) 1995-01-31
DK222790A (da) 1990-09-17
WO1989008709A1 (en) 1989-09-21
US5219579A (en) 1993-06-15
GB2217330B (en) 1992-08-26
GB2217330A (en) 1989-10-25
GB8906371D0 (en) 1989-05-04
GB8806471D0 (en) 1988-04-20

Similar Documents

Publication Publication Date Title
DK222790A (da) Biologisk aktivt materiale karakteriseret ved katabolisk aktivitet, alment associeret med cachexia-inducerende tumorer, praeparater, produktion og anvendelse deraf
DK142485D0 (da) Acyltripeptider, mellemprodukter ved deres fremstilling og farmaceutiske praeparater
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
DK0512026T3 (da) Syntetisk porøst krystallinsk materiale, dets fremstilling og anvendelse
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
DK535389D0 (da) Straekbart, ikke-vaevet tekstilmateriale og fremgangsmaade til fremstilling heraf
DK629688A (da) 4-formylaminopiperidin-derivater, anvendelse deraf som stabilisatorer og dermed stabiliseret, organisk materiale
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
DK155489D0 (da) Umaettede n-benzopyranyllactamer, deres fremstilling og anvendelse
DK475288D0 (da) Vandhaerdnende polymerpraeparat til konstruktionsmaterialer, deres fremstilling og anvendelse
DK451588A (da) Heterocycliske forbindelser, deres fremstilling og laegemidler indeholdende forbindelserne
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK371088A (da) Azacykliske forbindelser, deres fremstilling og anvendelse
DK419686A (da) Baerer til immobilisering af biologisk aktivt, og organisk materiale
NO860344L (no) Vevskultur og fremstilling i permeable geler.
NO851317L (no) Partikkelformig, belkende vaskemiddel og fremgangsmaate ved fremstilling derav.
DK698188D0 (da) Peptider, deres fremstilling og anvendelse
EP0507772A4 (en) NON-MELANOCYTIC, EUKARYOTIC CELL CONSTITUTIVELY EXPRESSING BIOLOGICALLY ACTIVE HUMAN TYROSINASE AND THEIR USE.
DK241686A (da) Carboxyalkyldipeptider, fremstilling deraf og farmaceutiske praeparater indeholdende disse
NO902248D0 (no) Renininhiberende peptider, deres fremstilling og anvendelse i legemidler.
DK489889D0 (da) Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler
DK10487A (da) 4-aminoaryldihydropyridinlactoner, deres fremstilling og anvendelse i laegemidler
DK592389A (da) Penemderivater, deres fremstilling og anvendelse
NO853212L (no) Materiale og metode for aa forbedre droevtyggeres forutnyttelse.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment